• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将纳米毒理学与 3Rs 原则相协调:为了实现短期、中期和长期的机会,我们需要做什么?

Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities?

机构信息

NC3Rs, Gibbs Building, 215 Euston Road, London NW1 2BE, UK.

EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), European Commission - Joint Research Centre (JRC), JRC F3 Chemical Safety and Alternative Methods in JRC Directorate F - Health, Consumers and Reference Materials, Via E. Fermi 2749, I-21027 Ispra, Italy.

出版信息

Regul Toxicol Pharmacol. 2017 Dec;91:257-266. doi: 10.1016/j.yrtph.2017.10.021. Epub 2017 Oct 22.

DOI:10.1016/j.yrtph.2017.10.021
PMID:29069581
Abstract

Nanomaterials convey numerous advantages, and the past decade has seen a considerable rise in their development and production for an expanse of applications. While the potential advantages of nanomaterials are clear, concerns over the impact of human and environmental exposure exist. Concerted, science-led efforts are required to understand the effects of nanomaterial exposure and ensure that protection goals are met. There is much on-going discussion regarding how best to assess nanomaterial risk, particularly considering the large number of tests that may be required. A plethora of forms may need to be tested for each nanomaterial, and risk assessed throughout the life cycle, meaning numerous acute and chronic toxicity studies could be required, which is neither practical nor utilises the current evidence-base. Hence, there are scientific, business, ethical and legislative drivers to re-consider the use of animal toxicity tests. An expert Working Group of regulators, academics and industry scientists were gathered by the UK's NC3Rs to discuss: i) opportunities being offered in the short, medium and long-terms to advance nanosafety, ii) how to align these advances with the application of the 3Rs in nanomaterial safety testing, and iii) shifting the focus of risk assessment from current hazard-based approaches towards exposure-driven approaches.

摘要

纳米材料具有许多优势,在过去十年中,它们的开发和生产得到了极大的发展,应用范围广泛。虽然纳米材料的潜在优势显而易见,但人们对人类和环境暴露的影响仍存在担忧。需要齐心协力,以科学为导向,努力了解纳米材料暴露的影响,并确保实现保护目标。关于如何最好地评估纳米材料风险,人们正在进行大量讨论,特别是考虑到可能需要进行大量测试。可能需要对每种纳米材料进行大量形式的测试,并在整个生命周期内进行风险评估,这意味着可能需要进行大量的急性和慢性毒性研究,这既不切实际,也无法利用当前的证据基础。因此,有科学、商业、伦理和立法方面的驱动因素需要重新考虑动物毒性测试的使用。英国 NC3Rs 召集了监管机构、学术界和行业科学家的专家工作组,讨论了:i)在短期、中期和长期内推进纳米安全性的机会,ii)如何将这些进展与 3R 在纳米材料安全测试中的应用相结合,以及 iii)将风险评估的重点从当前基于危害的方法转向基于暴露的方法。

相似文献

1
Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities?将纳米毒理学与 3Rs 原则相协调:为了实现短期、中期和长期的机会,我们需要做什么?
Regul Toxicol Pharmacol. 2017 Dec;91:257-266. doi: 10.1016/j.yrtph.2017.10.021. Epub 2017 Oct 22.
2
The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.化学安全评估中暴露驱动方法的现状:跨部门视角
Toxicology. 2017 Aug 15;389:109-117. doi: 10.1016/j.tox.2017.07.018. Epub 2017 Aug 1.
3
Aligning the 3Rs with new paradigms in the safety assessment of chemicals.使“3R原则”与化学品安全评估的新范式保持一致。
Toxicology. 2015 Apr 1;330:62-6. doi: 10.1016/j.tox.2015.01.014.
4
Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk.纳米毒理学中新兴的系统生物学方法:迈向基于机制的纳米材料危害与风险理解
Toxicol Appl Pharmacol. 2016 May 15;299:101-11. doi: 10.1016/j.taap.2015.12.014. Epub 2015 Dec 22.
5
Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.制定替代测试策略以指导纳米材料对人类健康风险评估的方法。
Risk Anal. 2016 Aug;36(8):1538-50. doi: 10.1111/risa.12645. Epub 2016 Jun 10.
6
Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.纳米材料安全性评价的研究策略,第二部分:纳米材料的毒理学与安全性评价、当前挑战及数据需求
Toxicol Sci. 2005 Nov;88(1):12-7. doi: 10.1093/toxsci/kfi293. Epub 2005 Aug 24.
7
Adoption of in vitro systems and zebrafish embryos as alternative models for reducing rodent use in assessments of immunological and oxidative stress responses to nanomaterials.采用体外系统和斑马鱼胚胎作为替代模型,以减少在评估纳米材料对免疫和氧化应激反应中的啮齿动物使用。
Crit Rev Toxicol. 2018 Mar;48(3):252-271. doi: 10.1080/10408444.2017.1404965. Epub 2017 Dec 14.
8
Nanomaterial health effects--part 1: background and current knowledge.纳米材料对健康的影响——第1部分:背景与当前认知。
WMJ. 2006 Mar;105(2):16-20.
9
Working in partnership to advance the 3Rs in toxicity testing.携手合作,推进毒理学 3R 原则。
Toxicology. 2010 Jan 12;267(1-3):14-9. doi: 10.1016/j.tox.2009.11.006. Epub 2009 Nov 10.
10
Advancing the 3Rs in regulatory ecotoxicology: A pragmatic cross-sector approach.推动监管生态毒理学中的3R原则:一种务实的跨部门方法。
Integr Environ Assess Manag. 2016 Jul;12(3):417-21. doi: 10.1002/ieam.1703. Epub 2015 Nov 1.

引用本文的文献

1
Predicting tissue distribution and tumor delivery of nanoparticles in mice using machine learning models.使用机器学习模型预测纳米颗粒在小鼠中的组织分布和肿瘤传递。
J Control Release. 2024 Oct;374:219-229. doi: 10.1016/j.jconrel.2024.08.015. Epub 2024 Aug 16.
2
Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment.用于癌症治疗的新型单克隆抗体药物偶联物开发过程中的商业风险缓解
Pharmaceutics. 2023 Jun 18;15(6):1761. doi: 10.3390/pharmaceutics15061761.
3
Daphnia as a model organism to probe biological responses to nanomaterials-from individual to population effects via adverse outcome pathways.
水蚤作为一种模式生物,用于通过不良结局途径探究对纳米材料的生物学反应——从个体效应到种群效应。
Front Toxicol. 2023 Apr 14;5:1178482. doi: 10.3389/ftox.2023.1178482. eCollection 2023.
4
Approach toward -Based Human Toxicity Effect Factors for the Life Cycle Impact Assessment of Inhaled Low-Solubility Particles.基于途径的吸入性低溶解性颗粒生命周期影响评价的人体毒性效应因子方法。
Environ Sci Technol. 2022 Jun 21;56(12):8552-8560. doi: 10.1021/acs.est.2c01816. Epub 2022 Jun 3.
5
An investigation of the hepatic toxicity of PEGylated polymeric redox responsive nanoparticles.聚乙二醇化聚合物氧化还原响应性纳米颗粒的肝毒性研究
RSC Adv. 2022 Apr 27;12(20):12860-12870. doi: 10.1039/d2ra00395c. eCollection 2022 Apr 22.
6
Experimental and Computational Nanotoxicology-Complementary Approaches for Nanomaterial Hazard Assessment.实验与计算纳米毒理学——纳米材料危害评估的互补方法
Nanomaterials (Basel). 2022 Apr 14;12(8):1346. doi: 10.3390/nano12081346.
7
Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials.将AOP框架中的科学进展转化为纳米材料的决策制定。
Nanomaterials (Basel). 2020 Jun 24;10(6):1229. doi: 10.3390/nano10061229.
8
Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology.读片(read-across)的国际化作为一种经过验证的新方法(NAM)用于监管毒理学。
ALTEX. 2020;37(4):579-606. doi: 10.14573/altex.1912181. Epub 2020 Apr 30.
9
Animal simulations facilitate smart drug design through prediction of nanomaterial transport to individual tissue cells.动物模拟通过预测纳米材料向单个组织细胞的转运来促进智能药物设计。
Sci Adv. 2020 Jan 22;6(4):eaax2642. doi: 10.1126/sciadv.aax2642. eCollection 2020 Jan.
10
Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies.纳米医学中的风险评估与风险最小化:对预测性、替代性和3R策略的需求。
Front Pharmacol. 2018 Mar 13;9:228. doi: 10.3389/fphar.2018.00228. eCollection 2018.